Bokf Na Has $3.01 Million Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Bokf Na trimmed its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 42.4% in the fourth quarter, HoldingsChannel reports. The firm owned 5,279 shares of the biotechnology company’s stock after selling 3,887 shares during the quarter. Bokf Na’s holdings in Axon Enterprise were worth $3,009,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of AXON. Tidal Investments LLC grew its stake in Axon Enterprise by 13.8% in the 3rd quarter. Tidal Investments LLC now owns 3,250 shares of the biotechnology company’s stock valued at $1,299,000 after buying an additional 394 shares during the last quarter. Principal Financial Group Inc. grew its position in shares of Axon Enterprise by 33.1% in the third quarter. Principal Financial Group Inc. now owns 136,302 shares of the biotechnology company’s stock valued at $54,466,000 after purchasing an additional 33,869 shares during the last quarter. Range Financial Group LLC acquired a new position in shares of Axon Enterprise in the fourth quarter valued at approximately $291,000. Wealth Enhancement Advisory Services LLC lifted its holdings in Axon Enterprise by 1.5% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 12,607 shares of the biotechnology company’s stock worth $7,493,000 after purchasing an additional 185 shares during the last quarter. Finally, HBW Advisory Services LLC bought a new stake in Axon Enterprise in the 4th quarter valued at $295,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

AXON has been the topic of several recent research reports. TD Cowen initiated coverage on Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective on the stock. JMP Securities reaffirmed an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Craig Hallum downgraded shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. Needham & Company LLC reaffirmed a “buy” rating and set a $600.00 target price on shares of Axon Enterprise in a report on Wednesday, April 23rd. Finally, Northcoast Research cut Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have issued a buy rating to the company. According to MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average target price of $626.45.

Insiders Place Their Bets

In other news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction dated Monday, April 21st. The stock was sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the sale, the chief executive officer now directly owns 3,063,982 shares of the company’s stock, valued at approximately $1,657,583,622.18. This trade represents a 0.33 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Jeri Williams sold 307 shares of the company’s stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the transaction, the director now directly owns 1,627 shares of the company’s stock, valued at $899,275.44. This represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. Insiders own 6.10% of the company’s stock.

Axon Enterprise Price Performance

Axon Enterprise stock opened at $600.35 on Thursday. The stock has a fifty day moving average of $558.13 and a 200-day moving average of $580.55. The stock has a market capitalization of $46.74 billion, a P/E ratio of 155.13, a price-to-earnings-growth ratio of 5.17 and a beta of 1.24. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. Axon Enterprise, Inc. has a 52 week low of $273.52 and a 52 week high of $715.99.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, topping analysts’ consensus estimates of $1.34 by $0.07. The firm had revenue of $603.63 million during the quarter, compared to analysts’ expectations of $585.67 million. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The business’s revenue for the quarter was up 31.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.15 earnings per share. On average, sell-side analysts expect that Axon Enterprise, Inc. will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.